For instance, a study examining the long-term nephroprotective effects of a DPP-4 inhibitor in db/db mice, a model of T2DM, showed it can delay the progression of DN damage in a glucose- and blood pressure-independent manner. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.